Reportlinker Adds Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global genetic testing market. The report provides market landscape, competitive landscape and market trends information on the genetic testing market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Inborn Gene or Chromosome Alterations, Acquired Gene or Chromosome Alterations, and Other Genetic Tests.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within genetic testing market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Qiagen, F. Hoffmann-La Roche, Abbott Laboratories, Hologic, Siemens Healthcare, and Biomerieux Sa.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the genetic testing market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the genetic testing market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global genetic testing market and the factors shaping it.
1 Table of contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 GlobalData Report Guidance 7
3 Genetic Testing Overview 8
3.1 Introduction 8
3.2 Major Diseases Diagnosed Using Genetic Testing 8
3.2.1 Hemophilia 8
3.2.2 Thalassemia 8
3.2.3 Sickle-cell Anemia 9
3.2.4 Cystic Fibrosis 9
3.2.5 Tay – Sachs Disease 9
3.2.6 Down Syndrome 9
3.2.7 Huntington's Disease 10
3.2.8 Mutations in Oncogenes 10
4 Genetic Testing: Market Characterization 11
4.1 Genetic Testing Market, Global, Revenue ($m), Historic, 2003-2010 11
4.2 Genetic Testing Market, Global, Revenue ($m), Forecast, 2010-2017 12
4.3 Genetic Testing Market, Key Trends 13
4.3.1 Increase in the Number of Genetic Tests Available for Diagnosis of Medical Conditions 13
4.3.2 Increased Awareness of Pre-natal and Pre-symptomatic Genetic Tests will Increase the Number of Individuals Undertaking Genetic Tests 14
4.4 Genetic Testing, Market Dynamics 15
4.4.1 Market Drivers 16
4.4.2 Market Restraints 17
5 Genetic Testing Market: Segment Analysis 18
5.1 Inborn Gene or Chromosome Alterations 18
5.2 Inborn Gene or Chromosome Alterations Market, Global, Revenue ($m), Historic, 2003-2010 19
5.3 Inborn Gene or Chromosome Alterations Market, Global, Revenue ($m), Forecast, 2010-2017 20
5.4 Inborn Gene or Chromosome Alterations, Market Dynamics 21
5.4.1 Market Driver: Increasing Awareness about the Role of Genomics in Susceptibility to Diseases has led to a Growth in Pre-natal testing 21
5.4.2 Market Restraint: Invasive Procedures for Prenatal Testing Increase the Risk of Miscarriages 21
5.5 Acquired Gene or Chromosome Alterations 22
5.6 Acquired Gene or Chromosome Alterations, Global, Revenue ($m), Historic, 2003-2010 22
5.7 Acquired Gene or Chromosome Alterations, Global, Revenue ($m), Forecast, 2010-2017 23
5.8 Acquired Gene or Chromosome Alterations, Market Dynamics 24
5.8.1 Market Driver: The Need for Early Diagnosis of Cancer and the Increasing Number of Cancer Patients is Boosting Genetic Testing 24
5.8.2 Market Restraint: High Costs Involved in Screening Procedures is Preventing Patients from Undertaking the Tests 24
5.9 Other Genetic Tests 24
5.10 Other Genetic Tests, Global, Revenue ($m), Historic, 2003-2010 25
5.11 Other Genetic Tests, Global, Revenue ($m), Forecast, 2010-2017 26
5.12 Other Genetic Tests, Market Dynamics 27
5.12.1 Market Driver: Shifting Focus on Personalized Medicine by Pharmaceutical Companies will lead to an Increase in the number of Genetic Tests 27
6 Genetic Testing Market, by Country, Revenue ($m), 2003 – 2017 28
6.1 Genetic Testing Market, the US, Revenue ($m), Historic, 2003 – 2010 28
6.2 Genetic Testing Market, the US, Revenue ($m), Forecast, 2010 – 2017 29
6.3 Genetic Testing Market, Canada, Revenue ($m), Historic, 2003 – 2010 30
6.4 Genetic Testing Market, Canada, Revenue ($m), Forecast, 2010 – 2017 31
6.5 Genetic Testing Market, the UK, Revenue ($'000), Historic, 2003 – 2010 32
6.6 Genetic Testing Market, the UK, Revenue ($'000), Forecast, 2010 – 2017 33
6.7 Genetic Testing Market, Germany, Revenue ($'000), Historic, 2003 – 2010 34
6.8 Genetic Testing Market, Germany, Revenue ($'000), Forecast, 2010 – 2017 35
6.9 Genetic Testing Market, France, Revenue ($'000), Historic, 2003 – 2010 36
6.10 Genetic Testing Market, France, Revenue ($'000), Forecast, 2010 – 2017 37
6.11 Genetic Testing Market, Italy, Revenue ($'000), Historic, 2003 – 2010 38
6.12 Genetic Testing Market, Italy, Revenue ($'000), Forecast, 2010 – 2017 39
6.13 Genetic Testing Market, Spain, Revenue ($'000), Historic, 2003 – 2010 40
6.14 Genetic Testing Market, Spain, Revenue ($'000), Forecast, 2010 – 2017 41
6.15 Genetic Testing Market, Japan, Revenue ($'000), Historic, 2003 – 2010 42
6.16 Genetic Testing Market, Japan, Revenue ($'000), Forecast, 2010 – 2017 43
6.17 Genetic Testing Market, China, Revenue ($'000), Historic, 2003 – 2010 44
6.18 Genetic Testing Market, China, Revenue ($'000), Forecast, 2010 – 2017 45
6.19 Genetic Testing Market, India, Revenue ($'000), Historic, 2003 – 2010 46
6.20 Genetic Testing Market, India, Revenue ($'000), Forecast, 2010 – 2017 47
6.21 Genetic Testing Market, Australia, Revenue ($'000), Historic, 2003 – 2010 48
6.22 Genetic Testing Market, Australia, Revenue ($'000), Forecast, 2010 – 2017 49
6.23 Genetic Testing Market, Brazil, Revenue ($'000), Historic, 2003 – 2010 50
6.24 Genetic Testing Market, Brazil, Revenue ($'000), Forecast, 2010 – 2017 51
7 Genetic Testing Market: Strategic Competitive Assessment 52
7.1 Genetic Testing Market, Key Market Participants 53
7.1.1 Qiagen N. V. 53
7.1.2 F. Hoffmann-La Roche Ltd. 56
7.1.3 Abbott Laboratories 59
7.1.4 Hologic Inc. 61
8 Genetic Testing Market: Strategic Pipeline Assessment 65
8.1 Pipeline Products Summary 65
8.2 Profiles of Promising Products Under Clinical Development 66
8.2.1 Verigene CYP2C19 Assay 66
8.2.2 KIF6 Test-Coronary Heart Disease 67
8.2.3 Biomarker for Breast Cancer Genetic Risk Assessment 69
8.2.4 AmoyDx Mutation Detection Kit 70
9 Genetic Testing Market: M&A Landscape 71
9.1 Genetic Testing Market: Deals Overview 71
9.2 Key Acquisitions 72
9.2.1 Danaher Acquires Beckman Coulter 72
9.2.2 Invitrogen Merges with Applied Biosystems to form Life Technologies 72
9.2.3 Qiagen Acquires Digene 73
9.2.4 LabCorp Completes Acquisition of Genzyme Genetics From Genzyme 73
9.2.5 Hologic Acquires Third Wave Technologies 73
10 Appendix 74
10.1 Definitions 74
10.1.1 Deoxyribonucleic Acid: 74
10.1.2 Ribonucleic Acid: 74
10.1.3 Chromosome: 74
10.1.4 Phenylketonuria: 74
10.1.5 Polymerase Chain Reaction: 74
10.1.6 Joint Venture 74
10.2 Acronyms 75
10.3 Research Methodology 76
10.4 Secondary Research 76
10.5 Primary Research 77
10.6 Models 77
10.7 Forecasts 77
10.8 Expert Panels 78
10.9 GlobalData Consulting 78
10.10 Contact Us 78
10.11 Disclaimer 78
1.1 List of Tables
Table 1: Genetic Testing Market, Global, Revenue ($m), 2003-2010 11
Table 2: Genetic Testing Market, Global, Revenue ($m), 2010-2017 12
Table 3: Inborn Gene or Chromosome Alterations Market, Global, Revenue ($m), 2003-2010 19
Table 4: Inborn Gene or Chromosome Alterations Market, Global, Revenue ($m), 2010-2017 20
Table 5: Acquired Gene or Chromosome Alterations, Global, Revenue ($m), 2003-2010 22
Table 6: Acquired Gene or Chromosome Alterations, Global, Revenue ($m), 2010-2017 23
Table 7: Other Genetic Tests, Global, Revenue ($m), 2003-2010 25
Table 8: Other Genetic Tests, Global, Revenue ($m), 2010-2017 26
Table 9: List of Drugs Affected due to Genetic Variation Among Patients 27
Table 10: Genetic Testing Market, the US, Revenue ($m), 2003 – 2010 28
Table 11: Genetic Testing Market, the US, Revenue ($m), 2010 – 2017 29
Table 12: Genetic Testing Market, Canada, Revenue ($m), 2003 – 2010 30
Table 13: Genetic Testing Market, Canada, Revenue ($m), 2010 – 2017 31
Table 14: Genetic Testing Market, the UK, Revenue ($'000), 2003 – 2010 32
Table 15: Genetic Testing Market, the UK, Revenue ($'000), 2010 – 2017 33
Table 16: Genetic Testing Market, Germany, Revenue ($'000), 2003 – 2010 34
Table 17: Genetic Testing Market, Germany, Revenue ($'000), 2010 – 2017 35
Table 18: Genetic Testing Market, France, Revenue ($'000), 2003 – 2010 36
Table 19: Genetic Testing Market, France, Revenue ($'000), 2010 – 2017 37
Table 20: Genetic Testing Market, Italy, Revenue ($'000), 2003 – 2010 38
Table 21: Genetic Testing Market, Italy, Revenue ($'000), 2010 – 2017 39
Table 22: Genetic Testing Market, Spain, Revenue ($'000), 2003 – 2010 40
Table 23: Genetic Testing Market, Spain, Revenue ($'000), 2010 – 2017 41
Table 24: Genetic Testing Market, Japan, Revenue ($'000), 2003 – 2010 42
Table 25: Genetic Testing Market, Japan, Revenue ($'000), 2010 – 2017 43
Table 26: Genetic Testing Market, China, Revenue ($'000), 2003 – 2010 44
Table 27: Genetic Testing Market, China, Revenue ($'000), 2010 – 2017 45
Table 28: Genetic Testing Market, India, Revenue ($'000), 2003 – 2010 46
Table 29: Genetic Testing Market, India, Revenue ($'000), 2010 – 2017 47
Table 30: Genetic Testing Market, Australia, Revenue ($'000), 2003 – 2010 48
Table 31: Genetic Testing Market, Australia, Revenue ($'000), 2010 – 2017 49
Table 32: Genetic Testing Market, Brazil, Revenue ($'000), 2003 – 2010 50
Table 33: Genetic Testing Market, Brazil, Revenue ($'000), 2010 – 2017 51
Table 34: Genetic Testing Market, Global, Company Revenue ($m), 2009 52
Table 35: Qiagen N. V. Marketed Products 53
Table 36: Qiagen N. V. Pipeline Products 53
Table 37: F. Hoffmann-La Roche Marketed Products 56
Table 38: Major Product Launches, F. Hoffmann-La Roche, 2011 57
Table 39: Key Product Launches, F. Hoffmann-La Roche, 2011 57
Table 40: Abbott Laboratories Marketed Products 60
Table 41: Hologic Inc. Marketed Products 62
Table 42: Hologic Inc. Pipeline Products 62
Table 43: Verigene CYP2C19 Assay, Product Description 66
Table 44: Verigene CYP2C19 Assay, Product Status 66
Table 45: KIF6 Test-Coronary Heart Disease, Product Description 67
Table 46: KIF6 Test-Coronary Heart Disease, Product Status 67
Table 47: KIF6 Test-Coronary Heart Disease, Clinical Trial 68
Table 48: Biomarker for Breast Cancer Genetic Risk Assessment, Product Description 69
Table 49: Biomarker for Breast Cancer Genetic Risk Assessment, Product Status 69
Table 50: AmoyDx Mutation Detection Kit, Product Description 70
Table 51: AmoyDx Mutation Detection Kit, Product Status 70
Table 52: Genetic Testing Market, Global, Number of Deals and Deal Value ($m), 2004-2010 71
1.2 List of Figures
Figure 1: Genetic Testing Market, Global, Revenue ($m), 2003-2010 11
Figure 2: Genetic Testing Market, Global, Revenue ($m), 2010-2017 12
Figure 3: Availability of Genetic Tests, Global, 1993-2010 13
Figure 4: Genetic Testing, Market Dynamics 15
Figure 5: Inborn Gene or Chromosome Alterations Market, Global, Revenue ($m), 2003-2010 19
Figure 6: Inborn Gene or Chromosome Alterations Market, Global, Revenue ($m), 2010-2017 20
Figure 7: Acquired Gene or Chromosome Alterations, Global, Revenue ($m), 2003-2010 22
Figure 8: Acquired Gene or Chromosome Alterations, Global, Revenue ($m), 2010-2017 23
Figure 9: Other Genetic Tests, Global, Revenue ($m), 2003-2010 25
Figure 10: Other Genetic Tests, Global, Revenue ($m), 2010-2017 26
Figure 11: Genetic Testing Market, the US, Revenue ($m), 2003 – 2010 28
Figure 12: Genetic Testing Market, the US, Revenue ($m), 2010 – 2017 29
Figure 13: Genetic Testing Market, Canada, Revenue ($m), 2003 – 2010 30
Figure 14: Genetic Testing Market, Canada, Revenue ($m), 2010 – 2017 31
Figure 15: Genetic Testing Market, the UK, Revenue ($'000), 2003 – 2010 32
Figure 16: Genetic Testing Market, the UK, Revenue ($'000), 2010 – 2017 33
Figure 17: Genetic Testing Market, Germany, Revenue ($'000), 2003 – 2010 34
Figure 18: Genetic Testing Market, Germany, Revenue ($'000), 2010 – 2017 35
Figure 19: Genetic Testing Market, France, Revenue ($'000), 2003 – 2010 36
Figure 20: Genetic Testing Market, France, Revenue ($'000), 2010 – 2017 37
Figure 21: Genetic Testing Market, Italy, Revenue ($'000), 2003 – 2010 38
Figure 22: Genetic Testing Market, Italy, Revenue ($'000), 2010 – 2017 39
Figure 23: Genetic Testing Market, Spain, Revenue ($'000), 2003 – 2010 40
Figure 24: Genetic Testing Market, Spain. Revenue ($'000), 2010 – 2017 41
Figure 25: Genetic Testing Market, Japan, Revenue ($'000), 2003 – 2010 42
Figure 26: Genetic Testing Market, Japan, Revenue ($'000), 2010 – 2017 43
Figure 27: Genetic Testing Market, China, Revenue ($'000), 2003 – 2010 44
Figure 28: Genetic Testing Market, China, Revenue ($'000), 2010 – 2017 45
Figure 29: Genetic Testing Market, India, Revenue ($'000), 2003 – 2010 46
Figure 30: Genetic Testing Market, India, Revenue ($'000), 2010 – 2017 47
Figure 31: Genetic Testing Market, Australia, Revenue ($'000), 2003 – 2010 48
Figure 32: Genetic Testing Market, Australia, Revenue ($'000), 2010 – 2017 49
Figure 33: Genetic Testing Market, Brazil, Revenue ($'000), 2003 – 2010 50
Figure 34: Genetic Testing Market, Brazil, Revenue ($'000), 2010 – 2017 51
Figure 35: Genetic Testing Market, Global, Company Share (%), 2009 52
Figure 36: Qiagen N. V. Deals Landscape 54
Figure 37: Qiagen N.V. SWOT Analysis 54
Figure 38: F. Hoffmann-La Roche Deals Landscape 56
Figure 39: F. Hoffmann-La Roche SWOT Analysis 58
Figure 40: Abbott Laboratories Deals Landscape 59
Figure 41: Abbott Laboratories SWOT Analysis 60
Figure 42: Hologic Inc. Deals Landscape 61
Figure 43: Hologic Inc. SWOT Analysis 62
Figure 44: Pipeline Products, by Segment, 2010 65
Figure 45: Genetic Testing Market, Global, Number of Deals and Deal Value ($m), 2004-2010 71Qiagen N. V.
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Hologic Inc.
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article